Heron Therapeutics Stock Recovery Opportunity After Patent Ruling

An analysis examines whether Heron Therapeutics, Inc. (HRTX) stock presents a recovery opportunity following a recent court ruling concerning its Cinvanti patent. Investors are evaluating the impact of the legal decision on the company's financial outlook and market position.